COVID-19 Sample Pooling: From RNA Extraction to Quantitative Real-time RT-PCR
Kenny Voon,
Nur Johari,
Khai Lim,
Siew Wong,
Loke Khaw,
Shew Wong,
Elaine Chan ,
Kok Chan,
Boon Tan,
Nurul Ramzi,
Patricia Lim,
Lokman Sulaiman
Affiliations
Kenny Voon
Pathology Division, School of Medicine, International Medical University, Kuala Lumpur, Malaysia
Nur Johari
Institute for Research, Development and Innovation (IRDI), International Medical University, Kuala Lumpur, Malaysia
Khai Lim
Institute for Research, Development and Innovation (IRDI), International Medical University, Kuala Lumpur, Malaysia
Siew Wong
Pathology Division, School of Medicine, International Medical University, Kuala Lumpur, Malaysia
Loke Khaw
Pathology Division, School of Medicine, International Medical University, Kuala Lumpur, Malaysia
Shew Wong
Pathology Division, School of Medicine, International Medical University, Kuala Lumpur, MalaysiaCentre for Environmental and Population Health Research, Institute for Research, Development and Innovation, International Medical University, Kuala Lumpur, Malaysia
Elaine Chan
Institute for Research, Development and Innovation (IRDI), International Medical University, Kuala Lumpur, Malaysia
Kok Chan
Human Biology Division, School of Medicine, International Medical University, Kuala Lumpur, Malaysia
Boon Tan
Human Biology Division, School of Medicine, International Medical University, Kuala Lumpur, Malaysia
Nurul Ramzi
Institute for Research, Development and Innovation (IRDI), International Medical University, Kuala Lumpur, Malaysia
Patricia Lim
Pathology Division, School of Medicine, International Medical University, Kuala Lumpur, MalaysiaInstitute for Research, Development and Innovation (IRDI), International Medical University, Kuala Lumpur, Malaysia
Lokman Sulaiman
Department of Community Medicine, School of Medicine, International Medical University, Kuala Lumpur, MalaysiaCentre for Environmental and Population Health Research, Institute for Research, Development and Innovation, International Medical University, Kuala Lumpur, Malaysia
The COVID-19 pandemic requires mass screening to identify those infected for isolation and quarantine. Individually screening large populations for the novel pathogen, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), is costly and requires a lot of resources. Sample pooling methods improve the efficiency of mass screening and consume less reagents by increasing the capacity of testing and reducing the number of experiments performed, and are therefore especially suitable for under-developed countries with limited resources. Here, we propose a simple, reliable pooling strategy for COVID-19 testing using clinical nasopharyngeal (NP) and/or oropharyngeal (OP) swabs. The strategy includes the pooling of 10 NP/OP swabs for extraction and subsequent testing via quantitative real-time reverse transcription polymerase chain reaction (RT-qPCR), and may also be applied to the screening of other pathogens.